Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC) Meeting Abstract


Authors: Venerito, M.; Rimassa, L.; Cicin, I.; Blanc, J. F.; Klümpen, H. J.; Zagonel, V.; Tran, A.; Kim, S.; Lin, Z. Z.; Tam, V. C.; Hazra, S.; Mangeshkar, M.; El-Khoueiry, A. B.; Cheng, A. L.; Meyer, T.; Kelley, R. K.; Abou-Alfa, G. K.
Abstract Title: Outcomes based on age in the phase 3 CELESTIAL trial of cabozantinib (C) versus placebo (P) in patients (pts) with advanced hepatocellular carcinoma (HCC)
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie
Journal Title: Oncology Research and Treatment
Volume: 41
Issue: Suppl. 4
Meeting Dates: 2018 Sep 28-Oct 2
Meeting Location: Vienna, Austria
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2018-09-01
Start Page: 283
Language: English
ACCESSION: WOS:000446816500688
PROVIDER: wos
PUBMED: 30261496
DOI: 10.1159/000492737
Notes: Meeting Abstract: P879 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ghassan Abou-Alfa
    568 Abou-Alfa